Liberty Leaf Holdings announced its subsidiary North Road Ventures submitted an abridgment to its Access to Cannabis for Medical Purposes Regulations application with Health Canada.
Liberty Leaf Holdings (CSE:LIB, OTCQB:LIBFF) announced its subsidiary North Road Ventures submitted an abridgment to its Access to Cannabis for Medical Purposes Regulations (ACMPR) application with Health Canada.
As quoted in the press release:
With the abridgment, North Road will have a distribution model that alleviates looming supply-chain issues, for “craft” or “artisan” licensed producers. Essentially, North Road is changing its application to become distribution-focused, making the company unique in the crowded field of other cultivation based applicants.
The abridgment includes further significant features that set North Road apart. The submission for an increase in product-vault capacity will result in a fivefold increase in products available for distribution. Also notable is the addition of cannabis oil products, expected to account for 50% or more of projected sales.